Birdwatch Note
2024-03-25 16:16:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Aucune étude sérieuse ne montre l'efficacité du protocole Raoult Les grandes agences de santé ne recommande pas l'usage de l'hydroxychloroquine contre le COVID du fait de son inutilité et ses dangers https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/hydroxychloroquine-treatment-covid-19/art-20555331#:~:text=FDA%20cautions%20against%20use%20of,U.S.%20Food%20and%20Drug%20Administration. L'usage de l'HCQ contre le COVID est la cause de milliers de morts https://www.radiofrance.fr/franceinter/covid-19-l-hydroxychloroquine-liee-a-pres-de-17-000-morts-lors-de-la-premiere-vague-selon-une-etude-9922908
Written by 2525A116715768A7CC42C4D4C38E8A47813D758DA9DE7F9DD237BFCE01BDCADB
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1772277179180613876
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1772296608832495918
- noteId - 1772296608832495918
- participantId -
- noteAuthorParticipantId - 2525A116715768A7CC42C4D4C38E8A47813D758DA9DE7F9DD237BFCE01BDCADB Participant Details
- createdAtMillis - 1711383413883
- tweetId - 1772277179180613876
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Aucune étude sérieuse ne montre l'efficacité du protocole Raoult Les grandes agences de santé ne recommande pas l'usage de l'hydroxychloroquine contre le COVID du fait de son inutilité et ses dangers https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/hydroxychloroquine-treatment-covid-19/art-20555331#:~:text=FDA%20cautions%20against%20use%20of,U.S.%20Food%20and%20Drug%20Administration. L'usage de l'HCQ contre le COVID est la cause de milliers de morts https://www.radiofrance.fr/franceinter/covid-19-l-hydroxychloroquine-liee-a-pres-de-17-000-morts-lors-de-la-premiere-vague-selon-une-etude-9922908
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-25 16:16:53 UTC (1711383413883) |
2024-03-25 18:29:39 UTC (1711391379754) |
CURRENTLY_RATED_HELPFUL | 2024-03-26 03:28:55 UTC (1711423735421) |
NEEDS_MORE_RATINGS | 2024-03-25 18:29:39 UTC (1711391379754) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-25 21:01:33 -0500 | Rating Details | |
2024-03-25 19:52:53 -0500 | Rating Details | |
2024-03-25 19:10:14 -0500 | Rating Details | |
2024-03-25 18:56:40 -0500 | Rating Details | |
2024-03-25 18:21:39 -0500 | Rating Details | |
2024-03-25 18:21:14 -0500 | Rating Details | |
2024-03-25 17:03:00 -0500 | Rating Details | |
2024-03-25 16:36:53 -0500 | Rating Details | |
2024-03-25 16:32:29 -0500 | Rating Details | |
2024-03-25 16:28:32 -0500 | Rating Details | |
2024-03-25 16:24:13 -0500 | Rating Details | |
2024-03-25 16:09:28 -0500 | Rating Details | |
2024-03-25 16:06:57 -0500 | Rating Details | |
2024-03-25 16:04:25 -0500 | Rating Details | |
2024-03-25 15:57:42 -0500 | Rating Details | |
2024-03-25 15:57:29 -0500 | Rating Details | |
2024-03-25 15:56:57 -0500 | Rating Details | |
2024-03-25 15:52:42 -0500 | Rating Details | |
2024-03-25 15:52:36 -0500 | Rating Details | |
2024-03-25 15:43:25 -0500 | Rating Details | |
2024-03-25 15:39:02 -0500 | Rating Details | |
2024-03-25 15:36:19 -0500 | Rating Details | |
2024-03-25 15:30:33 -0500 | Rating Details | |
2024-03-25 15:07:32 -0500 | Rating Details | |
2024-03-25 15:02:44 -0500 | Rating Details | |
2024-03-25 14:57:52 -0500 | Rating Details | |
2024-03-25 14:56:56 -0500 | Rating Details | |
2024-03-25 14:52:27 -0500 | Rating Details | |
2024-03-25 14:50:08 -0500 | Rating Details | |
2024-03-25 14:45:05 -0500 | Rating Details | |
2024-03-25 14:40:09 -0500 | Rating Details | |
2024-03-25 14:39:20 -0500 | Rating Details | |
2024-03-25 14:39:03 -0500 | Rating Details | |
2024-03-25 14:38:50 -0500 | Rating Details | |
2024-03-25 14:24:21 -0500 | Rating Details | |
2024-03-25 14:08:31 -0500 | Rating Details | |
2024-03-25 14:03:14 -0500 | Rating Details | |
2024-03-25 13:47:04 -0500 | Rating Details | |
2024-03-25 13:42:46 -0500 | Rating Details | |
2024-03-25 13:38:11 -0500 | Rating Details | |
2024-03-25 13:37:00 -0500 | Rating Details | |
2024-03-25 13:32:49 -0500 | Rating Details | |
2024-03-25 13:30:32 -0500 | Rating Details | |
2024-03-25 13:26:06 -0500 | Rating Details | |
2024-03-25 13:22:30 -0500 | Rating Details | |
2024-03-25 13:11:27 -0500 | Rating Details | |
2024-03-25 13:06:00 -0500 | Rating Details | |
2024-03-25 13:05:18 -0500 | Rating Details | |
2024-03-25 13:05:16 -0500 | Rating Details | |
2024-03-25 13:04:45 -0500 | Rating Details | |
2024-03-25 12:44:03 -0500 | Rating Details | |
2024-03-25 12:43:37 -0500 | Rating Details | |
2024-03-25 12:41:46 -0500 | Rating Details | |
2024-03-25 12:39:14 -0500 | Rating Details | |
2024-03-25 12:34:08 -0500 | Rating Details | |
2024-03-25 12:33:21 -0500 | Rating Details | |
2024-03-25 12:29:10 -0500 | Rating Details | |
2024-03-25 12:20:21 -0500 | Rating Details | |
2024-03-25 12:18:26 -0500 | Rating Details | |
2024-03-25 12:17:43 -0500 | Rating Details | |
2024-03-25 12:16:37 -0500 | Rating Details | |
2024-03-25 12:07:07 -0500 | Rating Details | |
2024-03-25 12:01:26 -0500 | Rating Details | |
2024-03-25 11:57:44 -0500 | Rating Details | |
2024-03-25 11:55:09 -0500 | Rating Details | |
2024-03-25 11:54:34 -0500 | Rating Details | |
2024-03-25 11:51:56 -0500 | Rating Details | |
2024-03-25 11:47:57 -0500 | Rating Details | |
2024-03-25 11:41:58 -0500 | Rating Details | |
2024-03-25 11:41:49 -0500 | Rating Details | |
2024-03-25 11:41:00 -0500 | Rating Details | |
2024-03-25 11:40:39 -0500 | Rating Details | |
2024-03-25 11:39:58 -0500 | Rating Details | |
2024-03-25 11:34:52 -0500 | Rating Details | |
2024-03-25 11:32:25 -0500 | Rating Details | |
2024-03-25 11:31:55 -0500 | Rating Details | |
2024-03-25 11:30:58 -0500 | Rating Details | |
2024-03-25 11:30:15 -0500 | Rating Details | |
2024-03-25 11:29:41 -0500 | Rating Details | |
2024-03-25 11:29:33 -0500 | Rating Details | |
2024-03-25 11:29:10 -0500 | Rating Details | |
2024-03-25 11:28:21 -0500 | Rating Details | |
2024-03-25 11:27:29 -0500 | Rating Details | |
2024-03-25 11:25:09 -0500 | Rating Details | |
2024-03-25 11:22:36 -0500 | Rating Details | |
2024-03-25 11:22:11 -0500 | Rating Details | |
2024-03-25 11:21:45 -0500 | Rating Details | |
2024-03-25 11:21:12 -0500 | Rating Details | |
2024-03-25 11:20:51 -0500 | Rating Details | |
2024-03-25 11:19:52 -0500 | Rating Details | |
2024-03-25 11:19:49 -0500 | Rating Details | |
2024-03-25 11:18:29 -0500 | Rating Details | |
2024-03-26 08:40:34 -0500 | Rating Details | |
2024-03-26 08:09:05 -0500 | Rating Details | |
2024-03-26 07:23:49 -0500 | Rating Details | |
2024-03-26 06:05:12 -0500 | Rating Details | |
2024-03-26 03:16:49 -0500 | Rating Details | |
2024-03-26 02:17:22 -0500 | Rating Details | |
2024-03-26 02:02:58 -0500 | Rating Details | |
2024-03-26 01:54:52 -0500 | Rating Details | |
2024-03-25 23:33:18 -0500 | Rating Details | |
2024-03-25 23:10:59 -0500 | Rating Details | |
2024-03-25 21:32:50 -0500 | Rating Details | |
2024-03-27 13:29:35 -0500 | Rating Details | |
2024-03-27 12:16:34 -0500 | Rating Details | |
2024-03-26 18:03:33 -0500 | Rating Details | |
2024-03-26 11:09:15 -0500 | Rating Details | |
2024-03-26 07:06:16 -0500 | Rating Details | |
2024-03-26 06:57:10 -0500 | Rating Details | |
2024-03-26 06:09:47 -0500 | Rating Details | |
2024-03-26 05:46:46 -0500 | Rating Details | |
2024-03-26 04:02:01 -0500 | Rating Details | |
2024-03-26 03:24:08 -0500 | Rating Details | |
2024-03-26 02:12:23 -0500 | Rating Details | |
2024-03-26 01:41:42 -0500 | Rating Details | |
2024-03-26 00:51:16 -0500 | Rating Details | |
2024-03-25 23:42:25 -0500 | Rating Details | |
2024-03-25 22:22:19 -0500 | Rating Details | |
2024-03-25 22:10:02 -0500 | Rating Details | |
2024-03-25 22:06:39 -0500 | Rating Details | |
2024-03-25 21:06:03 -0500 | Rating Details | |
2024-03-25 20:34:42 -0500 | Rating Details | |
2024-03-25 19:23:59 -0500 | Rating Details | |
2024-03-25 18:43:26 -0500 | Rating Details | |
2024-03-25 18:16:59 -0500 | Rating Details | |
2024-03-25 18:03:38 -0500 | Rating Details | |
2024-03-25 17:05:12 -0500 | Rating Details | |
2024-03-25 16:39:45 -0500 | Rating Details | |
2024-03-25 16:37:54 -0500 | Rating Details | |
2024-03-25 16:29:45 -0500 | Rating Details | |
2024-03-25 16:13:24 -0500 | Rating Details | |
2024-03-25 16:09:13 -0500 | Rating Details | |
2024-03-25 16:07:04 -0500 | Rating Details | |
2024-03-25 16:04:22 -0500 | Rating Details | |
2024-03-25 15:59:00 -0500 | Rating Details | |
2024-03-25 15:56:14 -0500 | Rating Details | |
2024-03-25 15:49:57 -0500 | Rating Details | |
2024-03-25 15:46:03 -0500 | Rating Details | |
2024-03-25 15:36:13 -0500 | Rating Details | |
2024-03-25 15:26:25 -0500 | Rating Details | |
2024-03-25 15:19:58 -0500 | Rating Details | |
2024-03-25 15:10:26 -0500 | Rating Details | |
2024-03-25 15:10:25 -0500 | Rating Details | |
2024-03-25 14:46:04 -0500 | Rating Details | |
2024-03-25 14:39:49 -0500 | Rating Details | |
2024-03-25 14:36:16 -0500 | Rating Details | |
2024-03-25 14:33:20 -0500 | Rating Details | |
2024-03-25 14:32:39 -0500 | Rating Details | |
2024-03-25 14:31:16 -0500 | Rating Details | |
2024-03-25 14:27:18 -0500 | Rating Details | |
2024-03-25 14:23:47 -0500 | Rating Details | |
2024-03-25 14:22:22 -0500 | Rating Details | |
2024-03-25 14:21:05 -0500 | Rating Details | |
2024-03-25 14:20:18 -0500 | Rating Details | |
2024-03-25 14:13:41 -0500 | Rating Details | |
2024-03-25 14:10:27 -0500 | Rating Details | |
2024-03-25 14:08:13 -0500 | Rating Details | |
2024-03-25 14:02:07 -0500 | Rating Details | |
2024-03-25 14:01:47 -0500 | Rating Details | |
2024-03-25 13:56:42 -0500 | Rating Details | |
2024-03-25 13:54:11 -0500 | Rating Details | |
2024-03-25 13:51:23 -0500 | Rating Details | |
2024-03-25 13:47:53 -0500 | Rating Details | |
2024-03-25 13:21:04 -0500 | Rating Details | |
2024-03-25 13:12:41 -0500 | Rating Details | |
2024-03-25 13:10:34 -0500 | Rating Details | |
2024-03-25 13:06:39 -0500 | Rating Details | |
2024-03-25 13:03:29 -0500 | Rating Details | |
2024-03-25 12:57:12 -0500 | Rating Details | |
2024-03-25 12:54:16 -0500 | Rating Details | |
2024-03-25 12:53:48 -0500 | Rating Details | |
2024-03-25 12:52:48 -0500 | Rating Details | |
2024-03-25 12:22:22 -0500 | Rating Details | |
2024-03-25 12:15:51 -0500 | Rating Details | |
2024-03-25 12:07:53 -0500 | Rating Details | |
2024-03-25 12:02:20 -0500 | Rating Details | |
2024-03-25 12:01:33 -0500 | Rating Details | |
2024-03-25 11:59:48 -0500 | Rating Details | |
2024-03-25 11:57:11 -0500 | Rating Details | |
2024-03-25 11:56:40 -0500 | Rating Details | |
2024-03-25 11:56:10 -0500 | Rating Details | |
2024-03-25 11:52:57 -0500 | Rating Details | |
2024-03-25 11:51:38 -0500 | Rating Details | |
2024-03-25 11:49:43 -0500 | Rating Details | |
2024-03-25 11:47:42 -0500 | Rating Details | |
2024-03-25 11:46:27 -0500 | Rating Details | |
2024-03-25 11:45:40 -0500 | Rating Details | |
2024-03-25 11:39:58 -0500 | Rating Details | |
2024-03-25 11:39:54 -0500 | Rating Details | |
2024-03-25 11:39:07 -0500 | Rating Details | |
2024-03-25 11:32:12 -0500 | Rating Details | |
2024-03-25 11:29:01 -0500 | Rating Details | |
2024-03-25 11:27:56 -0500 | Rating Details | |
2024-03-25 11:27:53 -0500 | Rating Details | |
2024-03-25 11:27:13 -0500 | Rating Details | |
2024-03-25 11:26:44 -0500 | Rating Details | |
2024-03-25 11:24:55 -0500 | Rating Details | |
2024-03-25 11:24:54 -0500 | Rating Details | |
2024-03-25 11:24:27 -0500 | Rating Details | |
2024-03-25 11:23:58 -0500 | Rating Details | |
2024-03-25 11:23:34 -0500 | Rating Details | |
2024-03-25 11:23:28 -0500 | Rating Details | |
2024-03-25 11:22:50 -0500 | Rating Details | |
2024-03-25 11:22:43 -0500 | Rating Details | |
2024-03-25 11:21:41 -0500 | Rating Details | |
2024-03-27 17:43:25 -0500 | Rating Details | |
2024-03-27 13:18:56 -0500 | Rating Details | |
2024-03-27 07:47:11 -0500 | Rating Details | |
2024-03-29 07:24:45 -0500 | Rating Details | |
2024-03-28 06:07:08 -0500 | Rating Details | |
2024-03-25 14:55:25 -0500 | Rating Details | |
2024-03-29 05:52:07 -0500 | Rating Details | |
2024-03-31 15:19:21 -0500 | Rating Details | |
2024-03-31 09:33:16 -0500 | Rating Details | |
2024-04-09 16:55:58 -0500 | Rating Details | |
2024-03-25 15:00:43 -0500 | Rating Details | |
2024-04-10 02:11:08 -0500 | Rating Details | |
2024-03-25 15:13:50 -0500 | Rating Details | |
2024-04-18 08:48:07 -0500 | Rating Details | |
2024-04-04 07:49:06 -0500 | Rating Details | |
2024-04-02 01:04:21 -0500 | Rating Details | |
2024-04-25 07:19:59 -0500 | Rating Details | |
2024-04-23 12:24:23 -0500 | Rating Details | |
2024-04-12 09:06:01 -0500 | Rating Details | |
2024-05-14 16:13:05 -0500 | Rating Details | |
2024-05-15 08:31:30 -0500 | Rating Details | |
2024-05-14 11:41:15 -0500 | Rating Details | |
2024-05-15 08:17:48 -0500 | Rating Details | |
2024-05-09 01:25:48 -0500 | Rating Details | |
2024-05-15 21:36:10 -0500 | Rating Details | |
2024-05-15 14:09:30 -0500 | Rating Details | |
2024-05-14 06:31:06 -0500 | Rating Details | |
2024-05-09 21:52:59 -0500 | Rating Details | |
2024-05-18 19:17:09 -0500 | Rating Details | |
2024-06-03 00:58:06 -0500 | Rating Details | |
2024-08-07 05:19:09 -0500 | Rating Details | |
2024-08-06 23:02:14 -0500 | Rating Details |